- Home
- LGCB vs HOTH Comparison
LGCB vs HOTH Comparison
Compare LGCB & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- HOTH
- Stock Information
- Founded
- LGCB 2011
- HOTH 2017
- Country
- LGCB Japan
- HOTH United States
- Employees
- LGCB N/A
- HOTH N/A
- Industry
- LGCB
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- LGCB
- HOTH Health Care
- Exchange
- LGCB Nasdaq
- HOTH Nasdaq
- Market Cap
- LGCB 6.1M
- HOTH 8.3M
- IPO Year
- LGCB 2023
- HOTH 2019
- Fundamental
- Price
- LGCB $1.90
- HOTH $0.97
- Analyst Decision
- LGCB
- HOTH Strong Buy
- Analyst Count
- LGCB 0
- HOTH 3
- Target Price
- LGCB N/A
- HOTH $4.00
- AVG Volume (30 Days)
- LGCB 1.1M
- HOTH 218.1K
- Earning Date
- LGCB 05-20-2025
- HOTH 05-20-2025
- Dividend Yield
- LGCB N/A
- HOTH N/A
- EPS Growth
- LGCB N/A
- HOTH N/A
- EPS
- LGCB N/A
- HOTH N/A
- Revenue
- LGCB $10,289,681.00
- HOTH N/A
- Revenue This Year
- LGCB N/A
- HOTH N/A
- Revenue Next Year
- LGCB N/A
- HOTH N/A
- P/E Ratio
- LGCB N/A
- HOTH N/A
- Revenue Growth
- LGCB N/A
- HOTH N/A
- 52 Week Low
- LGCB $1.22
- HOTH $0.58
- 52 Week High
- LGCB $57.05
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- LGCB 50.25
- HOTH 59.33
- Support Level
- LGCB $1.80
- HOTH $0.85
- Resistance Level
- LGCB $2.13
- HOTH $0.95
- Average True Range (ATR)
- LGCB 0.21
- HOTH 0.06
- MACD
- LGCB 0.02
- HOTH 0.02
- Stochastic Oscillator
- LGCB 39.80
- HOTH 95.42
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.